Inter Pharma PCL
SET:IP
Inter Pharma PCL
Total Equity
Inter Pharma PCL
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inter Pharma PCL
SET:IP
|
Total Equity
฿2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
D
|
Do Day Dream PCL
SET:DDD
|
Total Equity
฿4.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
Total Equity
฿1.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
K
|
Karmarts PCL
SET:KAMART
|
Total Equity
฿3.4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
28%
|
CAGR 10-Years
18%
|
|
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Total Equity
฿539.6m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
R
|
Rojukis International PCL
SET:KISS
|
Total Equity
฿1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Inter Pharma PCL
Glance View
Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.
See Also
What is Inter Pharma PCL's Total Equity?
Total Equity
2B
THB
Based on the financial report for Jun 30, 2025, Inter Pharma PCL's Total Equity amounts to 2B THB.
What is Inter Pharma PCL's Total Equity growth rate?
Total Equity CAGR 5Y
35%
Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for Inter Pharma PCL have been 34% over the past three years , 35% over the past five years .
